| Name | Title | Contact Details |
|---|
mercer island vterinary clinic is a Mercer Island, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 1984, Criticare Systems, Inc. is an international medical device company headquartered in Waukesha, Wisconsin.
ShiraTronics is in the early stages of developing new innovative therapies to combat debilitating migraine headache. ShiraTronics is focused on commercializing novel neuromodulation technologies to treat this large unmet clinical need for patients and physicians.
At Mach7, our purpose is simple: to deliver to healthcare professionals the tools they need to help their patients achieve better health outcomes. Every day, medical practitioners face the challenge of bringing together an immense amount of patient data from multiple disparate sources while also finding a way to make sense of it. They must contend with issues like non-consolidated image storage, labor-intensive and inefficient workflows, and multiple viewers for different specialties and image types. With these obstacles in mind, Mach7 has built innovative solutions from the ground up that can integrate multiple systems, enable clinical collaboration, deliver vendor neutral archiving, provide enterprise-wide universal viewing, modernize legacy PACS, and more. Mach7 is focused on removing the technology limitations that inhibit the free flow of patient information and access to the complete patient medical record. We differ from many other companies in the industry by building an integrated imaging ecosystem where all technologies work together in harmony. Because we are built as an integration platform first, we give you the freedom to use the technologies that are important to your physicians and patients, even if they are from another vendor. This also means we offer the independence and flexibility to deploy these as individual components or a comprehensive end-to-end enterprise imaging platform. Through this, we help organizations increase their efficiency, achieve profound operational cost savings, leverage their existing IT investments, improve the experience for patients and medical professionals, and, ultimately, support healthier outcomes.
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.